Pediatrix Medical Group, Inc. - Common Stock (MD)

Historical Holders from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
MD on NYSE
Shares outstanding
87,648,727
Price per share
$21.39
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
80,599,871
Total reported value
$1,349,844,850
% of total 13F portfolios
0%
Share change
-287,509
Value change
-$1,869,965
Number of holders
266
Price from insider filings
$21.39
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Pediatrix Medical Group, Inc. - Common Stock (MD) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 15% $180,431,822 12,512,609 BlackRock, Inc. 30 Jun 2025
Rubric Capital Management LP 3.7% $42,535,424 3,148,440 Rubric Capital Management LP 31 Dec 2024
ALLIANCEBERNSTEIN L.P. 2.2% -72% $29,888,216 -$76,328,494 1,928,272 -72% AllianceBernstein L.P. 31 May 2025
As of 30 Sep 2025, Pediatrix Medical Group, Inc. - Common Stock (MD) has 266 institutional shareholders filing 13F forms. They hold 80,599,871 shares. of 87,648,727 outstanding shares (92%) .

Top 25 institutional shareholders own 69% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
BlackRock, Inc. 16% 13,849,278 -0.71% 0% $231,975,399
VANGUARD GROUP INC 12% 10,892,883 -0.84% 0% $182,455,791
VICTORY CAPITAL MANAGEMENT INC 4.7% 4,126,207 +31% 0.04% $69,113,968
STATE STREET CORP 4% 3,530,700 +1.2% 0% $59,139,225
DIMENSIONAL FUND ADVISORS LP 3.9% 3,399,778 +2.5% 0.01% $56,941,998
AMERICAN CENTURY COMPANIES INC 3.1% 2,682,976 +39% 0.02% $44,939,866
FMR LLC 2.5% 2,204,537 -8.7% 0% $36,925,990
GEODE CAPITAL MANAGEMENT, LLC 2.5% 2,167,291 +8.4% 0% $36,307,396
D. E. Shaw & Co., Inc. 2.3% 2,021,337 +28% 0.03% $33,857,395
Nuveen, LLC 1.8% 1,551,275 +85% 0.01% $25,983,857
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.7% 1,447,240 +14% 0% $24,241,270
Boston Partners 1.6% 1,427,953 +0.59% 0.02% $24,062,862
RENAISSANCE TECHNOLOGIES LLC 1.5% 1,306,000 +8.5% 0.03% $21,875,500
MORGAN STANLEY 1.5% 1,279,411 -2.8% 0% $21,430,146
Qube Research & Technologies Ltd 1.3% 1,143,306 +55% 0.03% $19,150,376
NORTHERN TRUST CORP 1.1% 932,680 +2.5% 0% $15,622,391
Invesco Ltd. 1% 877,019 +48% 0% $14,690,069
ALLIANCEBERNSTEIN L.P. 0.96% 839,886 -54% 0% $14,068,091
JPMORGAN CHASE & CO 0.94% 827,075 +20% 0% $13,853,506
Dana Investment Advisors, Inc. 0.91% 801,462 +5.6% 0.39% $13,424,489
GOLDMAN SACHS GROUP INC 0.87% 766,555 -3% 0% $12,839,789
CastleKnight Management LP 0.78% 682,000 -3.4% 0.61% $11,423,500
AMERIPRISE FINANCIAL INC 0.77% 671,749 -9.8% 0% $11,251,796
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.74% 646,792 +13% 0.23% $10,833,766
BRANDES INVESTMENT PARTNERS, LP 0.72% 630,711 +12% 0.08% $10,564,409

Institutional Holders of Pediatrix Medical Group, Inc. - Common Stock (MD) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 352,509 $7,605,177 -$1,791,316 $21.39 9
2025 Q3 80,599,871 $1,349,844,850 -$1,869,965 $16.75 266
2025 Q2 80,728,834 $1,157,863,224 +$486,090 $14.35 264
2025 Q1 80,224,836 $1,161,325,379 -$29,361,467 $14.49 239
2024 Q4 82,290,564 $1,079,965,205 -$29,993,590 $13.12 227
2024 Q3 85,681,136 $993,063,509 -$10,650,947 $11.59 215
2024 Q2 87,375,971 $659,214,098 -$5,501,442 $7.55 223
2024 Q1 84,089,821 $843,143,044 +$22,922,472 $10.03 208
2023 Q4 66,286 $616,460 +$166,861 $9.30 3
2023 Q3 81,218,393 $1,032,358,772 -$2,257,236 $12.71 193
2023 Q2 80,715,740 $1,147,005,006 -$35,053,370 $14.21 205
2023 Q1 83,670,652 $1,247,413,541 -$7,694,242 $14.91 205
2022 Q4 84,289,560 $1,252,664,684 +$2,055,346 $14.86 197
2022 Q3 83,286,280 $1,375,376,275 +$4,664,573 $16.51 189
2022 Q2 83,119,112 $1,746,722,757 +$55,336,104 $21.01 178
2022 Q1 84,354,933 $1,980,792,866 +$15,818,707 $23.48 202
2021 Q4 78,091,868 $2,124,668,604 -$17,824,496 $27.21 191
2021 Q3 83,599,296 $2,376,553,426 -$120,838,719 $28.43 209
2021 Q2 88,173,164 $2,658,283,085 -$57,806,170 $30.15 210
2021 Q1 90,809,328 $2,312,766,242 -$22,759,775 $25.47 201
2020 Q4 91,902,241 $2,254,977,725 +$251,889,177 $24.54 186
2020 Q3 83,250,480 $1,355,111,381 -$37,900,625 $16.28 190
2020 Q2 85,675,203 $1,464,265,374 +$63,145,485 $17.10 194
2020 Q1 79,611,149 $926,738,985 -$17,391,007 $11.64 198
2019 Q4 78,373,959 $2,177,506,488 -$4,653,800 $27.79 242
2019 Q3 78,816,416 $1,782,234,706 -$6,465,224 $22.62 213
2019 Q2 77,538,640 $1,955,108,661 +$26,040,053 $25.23 233
2019 Q1 78,725,467 $2,138,821,529 -$117,629,778 $27.17 273
2018 Q4 82,232,527 $2,713,132,994 -$256,568,085 $33.00 288
2018 Q3 87,974,176 $4,103,648,519 +$258,469 $46.66 310
2018 Q2 87,067,470 $3,768,489,660 -$74,230,037 $43.28 308
2018 Q1 90,909,443 $5,056,278,147 -$85,970,744 $55.63 333
2017 Q4 92,511,018 $4,943,559,869 +$71,721,763 $53.44 318
2017 Q3 92,322,895 $3,981,142,265 -$195,876,983 $43.12 328
2017 Q2 94,685,546 $5,715,839,282 -$351,694,123 $60.37 324
2017 Q1 99,112,562 $6,875,094,567 +$635,291,318 $69.38 353
2016 Q4 95,372,411 $6,358,006,036 +$58,305,665 $66.66 376
2016 Q3 94,355,039 $6,248,330,187 +$162,892,884 $66.25 375
2016 Q2 91,789,441 $6,638,655,253 +$92,136,685 $72.43 383
2016 Q1 88,464,837 $5,721,381,903 -$10,587,275 $64.62 371
2015 Q4 94,591,524 $6,780,437,640 +$239,977,791 $71.66 392
2015 Q3 90,953,053 $6,985,029,453 -$756,345,458 $76.79 374
2015 Q2 96,302,445 $7,136,780,333 +$166,154,330 $74.11 355
2015 Q1 95,034,079 $6,887,622,948 -$164,753,899 $72.51 351
2014 Q4 97,461,526 $6,442,574,000 -$154,034,989 $66.11 332
2014 Q3 99,323,995 $5,445,164,402 +$41,266,398 $54.82 325
2014 Q2 98,415,807 $5,722,894,613 -$103,798,047 $58.15 332
2014 Q1 100,315,314 $6,216,397,350 -$135,085,807 $61.98 317